文献速递心境障碍

辅助心理治疗预防双相障碍复发:一项随机临床试验

Adjuvant Psychotherapies to Prevent Relapse in Bipolar Disorder: A Randomized Clinical Trial.
PubMed 文献 · JAMA Psychiatry · 2024-01-01

在德国9个临床门诊单位开展观察者盲法随机临床试验,305例心境正常的双相障碍1型或2型患者随机接受SEKT或FEST团体心理治疗各24小时。两种治疗预防新发情感发作效果相当(SEKT复发69例[49%],FEST复发63例[46%]),双相障碍2型患者复发率最高(60例[61%]),尤其接受SEKT者(39例[70%])。

要点

  • SEKT与FEST预防新发情感发作效果相当,SEKT复发69例(49%),FEST复发63例(46%)。
  • 双相障碍2型患者复发率最高(60例[61%]),尤其接受SEKT治疗者(39例[70%])。
  • 结局由双相障碍2型、共病、完成全部治疗次数及治疗类型与双相障碍1型或2型的交互作用预测。

核心结论

  • 结构化的、技能导向的、基于材料的认知行为治疗(SEKT)与支持性的、以患者为中心的、情绪聚焦治疗(FEST)在以新的强化团体形式实施时,预防情感发作复发的效果相当。
  • 存在基线因素影响结局,尤其是双相障碍2型。

研究设计与样本

  • 这是一项大型、观察者盲法、随机临床试验,历时18个月(治疗后6个月评估;12个月和18个月随访)。
  • 在德国9个临床门诊单位,每名参与者在常规精神科治疗(包括心境稳定药物)基础上,接受24小时团体心理治疗,分4个全天 session,分布在5个月内。
  • 年龄18至50岁、心境正常的双相障碍1型或2型患者随机分配至SEKT或FEST。
  • 由对患者分组不知情的独立临床医生使用结构化访谈(DSM障碍结构化临床访谈和纵向间隔随访评估)以及自评和临床医生评定量表进行纳入标准和结局评估。
  • 计算Kaplan-Meier生存曲线分析至复发时间;采用Cox比例风险统计和倾向评分匹配进行多变量分析;研究数据于2020年3月至2022年9月分析。

主要发现

  • 筛查348例转诊患者,纳入305例心境正常的双相障碍1型或2型患者(中位[IQR]年龄34[18-50]岁;男性162例[53%])。
  • 207例(68%)为双相障碍1型,98例(32%)为双相障碍2型,278例(91%)接受精神科治疗。
  • 两种治疗预防新发发作效果相当;结局(新发发作率较高)不由治疗种类预测(SEKT:69例[49%]复发;FEST:63例[46%]复发)。
  • 结局由双相障碍2型、共病、完成全部治疗次数以及治疗类型与双相障碍1型或2型的交互作用预测。
  • 双相障碍2型患者复发率最高(60例[61%]复发),尤其是接受SEKT治疗者(39例[70%]复发)。

关键数值与推荐

  • 主要结局指标为盲法访谈者使用LIFE访谈评估的新发情感发作复发。
  • SEKT干预是结构化的认知行为治疗,整合了人际社会节律治疗和正念认知治疗的元素。
  • FEST心理治疗根源于情绪聚焦、支持性和非指导性治疗。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Several psychotherapy protocols have been evaluated as adjuncts to pharmacotherapy for patients with bipolar disorder (BD). Little is known about their comparative effectiveness. OBJECTIVE: To compare the effectiveness of 2 types of group psychotherapy, skill-oriented, material-based cognitive behavioral therapy (SEKT) and supportive, patient-centered, emotion-focused therapy (FEST), to prevent relapse in patients with euthymic BD. DESIGN, SETTING, AND PARTICIPANTS: This was a large, observer-blind, randomized clinical trial conducted over 18 months (posttreatment after 6 months; follow-up at 12 and 18 months). In addition to psychiatric care as usual (including mood-stabilizing medication), each participant at 9 clinical outpatient units in Germany received 24 hours of group psychotherapy over 4, full-day sessions spread over 5 months. Patients with euthymic BD type 1 (BD 1) or BD type 2 (BD 2) between the ages of 18 and 50 years were randomly assigned to 1 of 2 forms of psychotherapy, SEKT or FEST. Independent clinicians blinded to patient grouping performed assessments using structured interviews (Structured Clinical Interview for DSM Disorders and Longitudinal Interval Follow-Up Evaluation) and self-rating and clinician rating for inclusion criteria and outcome. Kaplan-Meier survival curves were calculated for time to relapse. Cox proportional hazards statistics and propensity score matching were calculated for the multivariate analysis. Study data were analyzed from March 2020 to September 2022. INTERVENTIONS: SEKT intervention is a structured cognitive behavioral therapy integrating elements of interpersonal social rhythm therapy, and of mindfulness-based cognitive therapy. FEST psychotherapy has its roots in emotion-focused, supportive, and nondirective therapy. MAIN OUTCOMES AND MEASURES: Recurrence of a new affective episode assessed by blinded interviewer with the LIFE interview. In addition, self-rating and clinician rating of depressive and mania symptoms as well as level of social functioning were assessed. RESULTS: Of 348 screened referrals, 305 patients (median [IQR] age, 34 [18-50] years; 162 male [53%]) with euthymic BD 1 or BD 2 were included in the study. A total of 207 patients (68%) had BD 1, 98 (32%) had BD 2, and 278 (91%) received psychiatric care. Both therapies were equally effective in preventing recurrence of a new episode. Outcome (higher rate of new episodes) was not predicted by kind of treatment (SEKT: 69 [49%] relapse; FEST: 63 [46%] relapse) but was predicted by BD 2, comorbidity, attending all sessions, and the interaction of type of treatment by BD 1 or 2. Patients with BD 2 had the highest rate of relapse (60 [61%] relapse), in particular, when treated by SEKT (39 [70%] relapse). CONCLUSIONS AND RELEVANCE: Results of this randomized clinical trial revealed that a structured, skill-oriented, material-based cognitive behavioral therapy (SEKT) and a supportive, patient-centered, emotion-focused therapy (FEST) were equally effective in preventing relapse of affective episodes when delivered in a new, intensive group format. Additionally, there were baseline factors, in particular BD 2, that influenced outcomes. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02506322.

来源:JAMA Psychiatry,查看原文。版权归原作者所有。

引用

  1. Hautzinger M. Adjuvant Psychotherapies to Prevent Relapse in Bipolar Disorder: A Randomized Clinical Trial. JAMA Psychiatry. 2024. PMID: 38837133. doi:10.1001/jamapsychiatry.2024.1310

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。